Table 1 Baseline characteristics of the study population.

From: Rapid improvements and subsequent effects in major depressive disorder patients with somatic pain using rTMS combined with sertraline

 

DT group (n = 37)

CT group (n = 38)

P

Female (%)

29 (78.4)

28 (73.7)

0.788

Age(years)

42.9 ± 10.5

43.9 ± 10.7

0.682

Course of disease(month)

4.0 ± 3.2

4.0 ± 3.7

0.934

HAMD

31.6 ± 8.3

32.4 ± 8.1

0.685

HAMA

24.1 ± 7.3

23.3 ± 6.4

0.631

NRS

7.0 ± 1.4

6.9 ± 1.3

0.744

MMN latency (ms)

221.2 ± 27.1

224.8 ± 28.2

0.181

P300 latency (ms)

394.8 ± 27.2

392.2 ± 28.5

0.697

P300 amplitude (uv)

2.7 ± 2.2

2.5 ± 3.5

0.680

  1. Results are shown as n (%) for the X2 test and mean ± SD for the independent t-test (two-tailed). DT the drug therapy group, CT the drug and rTMS combined therapy group.
Back to article page